Tuesday morning, right before the S&P 500 (SPX) ripped 2% in a straight line into today, I offered a quick take on the technical set up of the index using a few time-frames (MorningWord 5/24/16: Fool Me Twice? – …
Continue readingABBV
When market participants lack confidence in the underpinnings of the investment environment they quickly turn to technical analysis as their main trading input (there are some traditionalists with a long timer horizon that still view …
Continue reading
This morning Bloomberg News highlighted a research note from RBC technical analyst Robert Sluymer: S&P 500 Rally Can Continue on Momentum, Breadth: RBC’s Sluymer By Andrew Cinko (Bloomberg) — S&P 500 range bound for months, …
Continue reading
Well, this one was wrong right out of the gate. Eight days ago we put on an out of the money put spread in IBB, the biotech etf. The thought was that if the small …
Continue reading
The Biotech sector has been a massive out-performer over the last year, with the IBB (iShares Nasdaq Biotech etf) up 13% in 2015, and up 65% since from the 52 week lows made in April of last …
Continue reading
On October 31st GILD shares were trading at new all time highs, gaining 57% on the year, or about $80 billion in market cap. Since those highs the stock has sold off almost 15%, and …
Continue reading
VIX spot has made a round trip from 16 to 31 and back to 16 in less than 2 weeks. The S&P 500 index has been volatile on the way up as well as down, …
Continue reading
As we parse the market for stocks that are holding up well that still look attractive fundamentally, the pickings are increasingly slim. However, one of our prior favorites from earlier this year, Abbvie, has maintained …
Continue reading
Here is a quick recap of all of the trades that we initiated, closed, managed, expired and considered (Name That Trades) in the week that was June 30th – July 3rd:
Continue reading
We have been watching ABBV with frustration over the past month, as the stock has flirted with breaking out to a new all-time high on many occasions, but has failed each time: The inability of …
Continue reading